- Home
- OCG vs VNRX Comparison
OCG vs VNRX Comparison
Compare OCG & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCG
- VNRX
- Stock Information
- Founded
- OCG 2018
- VNRX N/A
- Country
- OCG Hong Kong
- VNRX United States
- Employees
- OCG N/A
- VNRX N/A
- Industry
- OCG Other Consumer Services
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OCG Consumer Discretionary
- VNRX Health Care
- Exchange
- OCG Nasdaq
- VNRX Nasdaq
- Market Cap
- OCG 65.5M
- VNRX 69.7M
- IPO Year
- OCG 2020
- VNRX N/A
- Fundamental
- Price
- OCG $3.24
- VNRX $0.42
- Analyst Decision
- OCG
- VNRX Strong Buy
- Analyst Count
- OCG 0
- VNRX 4
- Target Price
- OCG N/A
- VNRX $3.50
- AVG Volume (30 Days)
- OCG 12.9K
- VNRX 967.5K
- Earning Date
- OCG 11-11-2025
- VNRX 11-13-2025
- Dividend Yield
- OCG N/A
- VNRX N/A
- EPS Growth
- OCG N/A
- VNRX N/A
- EPS
- OCG N/A
- VNRX N/A
- Revenue
- OCG $622,690.00
- VNRX $1,319,252.00
- Revenue This Year
- OCG N/A
- VNRX $324.32
- Revenue Next Year
- OCG N/A
- VNRX $247.82
- P/E Ratio
- OCG N/A
- VNRX N/A
- Revenue Growth
- OCG N/A
- VNRX 35.10
- 52 Week Low
- OCG $1.06
- VNRX $0.40
- 52 Week High
- OCG $7.47
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- OCG 30.00
- VNRX 32.42
- Support Level
- OCG $3.00
- VNRX $0.43
- Resistance Level
- OCG $3.55
- VNRX $0.48
- Average True Range (ATR)
- OCG 0.22
- VNRX 0.04
- MACD
- OCG -0.07
- VNRX -0.00
- Stochastic Oscillator
- OCG 12.77
- VNRX 5.83
About OCG Oriental Culture Holding LTD
Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance services to customers. The company operates through one segment, namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.